Arbutus 20drillcover 20product 20family 20 small
Logos 03

Arbutus Medical

Arbutus Medical developed the DrillCover - a surgical drill system that costs 30x less competitors - to reduce costs of surgery and improve access for patients.

  • Stage $1M in TTM Revenue
  • Industry Medical Devices and Equipment
  • Location Vancouver, BC, Canada
  • Currency CAD
  • Founded December 2014
  • Employees 13
  • Incorporation Type C-corp
  • Website arbutusmedical.ca

Company Summary

Arbutus Medical’s purpose is to develop a portfolio of frugal innovations that save costs for hospitals and improve access to orthopaedic surgery for 5 million patients by 2030.

Arbutus launched its DrillCover in late 2016, focused on low-income countries for 2 years, then pivoted and validated fit in veterinary (62% YoY growth), military (sales to US and Canadian militaries), and US Trauma Centers. Arbutus has enabled 58,000 surgeries to date.

Team

  • Lb 20headshot 202020 05 1
    CEO / Co-founder

    Masters in biomedical engineering from UBC. Orthopaedic research background. Led Operations 2015-2018; took CEO role in Dec 2018 and led pivots.

  • Default avatar
    Elise Huisman
    Veterinary Sales / Co-founder

    PhD (orthopaedic research) and YWCA Vancouver Women of Distinction nominee 2020. Built veterinary sales division.

  • 20+ years commercializing medtech (Pyng, Angiometrix, Evasc).

  • 5bc6684f 60f1 4653 8db2 dd4105194bfe
    Trauma Center Sales

    MBA, 5 years sales/product mgmt (Conmed, Muse).

  • 34792dc2 e13e 4cb2 a348 0bc220f8a196
    Marketing

    15+ years in sales & marketing (incl. B2B hardware & channels).

  • Img 6636
    Engineering / Co-founder

    Verathon Medical and UBC MEng background; built Arbutus IP strategy, regulatory strategy, product roadmap, and DEWALT partnership.

  • Default avatar
    Michael Liggett
    Finance

    20 years raising capital (over $300M) and M&A deals ($200M).

Advisors

  • Default avatar
    Dr. Piotr Blachut
    Advisor - Orthopaedic Surgery
    Unconfirmed
    Default avatar
    Dr. Peter O'Brien
    Unconfirmed

Previous Investors